Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
25.45
+0.81 (3.29%)
Apr 8, 2026, 9:25 AM EDT - Market open
Syndax Pharmaceuticals Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$38.69
Upside
+52.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $34 | Strong Buy | Maintains | $28 → $34 | +33.60% | Apr 1, 2026 |
| Mizuho | Mizuho | Buy Maintains $45 → $43 | Buy | Maintains | $45 → $43 | +68.96% | Mar 31, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $48 → $40 | Strong Buy | Initiates | $48 → $40 | +57.17% | Mar 30, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $33 → $45 | Buy | Maintains | $33 → $45 | +76.82% | Mar 9, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $51 → $57 | Strong Buy | Maintains | $51 → $57 | +123.97% | Mar 2, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +120.04% | Dec 9, 2025 |
| Barclays | Barclays | Buy Maintains $22 → $35 | Buy | Maintains | $22 → $35 | +37.52% | Nov 24, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $33 | Buy | Maintains | $40 → $33 | +29.67% | Nov 12, 2025 |
| UBS | UBS | Strong Buy Maintains $35 → $38 | Strong Buy | Maintains | $35 → $38 | +49.31% | Nov 4, 2025 |
| Barclays | Barclays | Buy Maintains $19 → $22 | Buy | Maintains | $19 → $22 | -13.56% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +57.17% | Oct 27, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +120.04% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +57.17% | Oct 16, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +120.04% | Sep 19, 2025 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +72.89% | Sep 10, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | -5.70% | Sep 5, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.